AstraZeneca plc (NASDAQ:AZN) has been granted approval by the U.S. Food and Drug Administration for a new self-injection ...

That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...

This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...

If someone you love has lupus, you know that living with lupus brings challenges not only for them but also for their friends and family. But you are not alone in this fight, and although it may be ...

In the final part of her interview, Margrit Wiesendanger, MD, PhD, discusses the need to improve lupus care by addressing social determinants of health and expanding access to treatment. In the fourth ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Approximately 1.5 million people in the United States have a form of lupus, with 60% developing lupus nephritis, according to the Lupus Foundation of America. Of these, 90% tend to be females aged 15 ...

Please provide your email address to receive an email when new articles are posted on . Identifying negative social determinants of health can improve outcomes in lupus. Physician education is needed ...

Precision immunotherapy strategies are redefining systemic lupus erythematosus treatment by targeting immune pathways. Read ...

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and ...

Hundreds of lupus advocates from 42 states gathered in Washington, DC for the Lupus Foundation of America's National Lupus ...